Advertisement
Screener

VYOME HOLDINGS, INC. (HIND) Depreciation

2.8 / 5 stars · 68/120 Roast Me

VYOME HOLDINGS, INC. Depreciation

VYOME HOLDINGS, INC. (HIND) reported Depreciation of $8.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.

Financial Statements › Cash Flow › Operating Activities

us-gaap:Depreciation · last filed 2025-08-14

  • VYOME HOLDINGS, INC. depreciation for the quarter ending 2025-06-30 was $4.00K, a 33.33% decline year-over-year.
  • VYOME HOLDINGS, INC. depreciation for the quarter ending 2025-03-31 was $4.00K, a 33.33% decline year-over-year.
  • VYOME HOLDINGS, INC. depreciation for the quarter ending 2024-12-31 was $5.00K, a 28.57% decline year-over-year.
  • VYOME HOLDINGS, INC. depreciation for the quarter ending 2024-09-30 was $5.00K, a 87.18% decline year-over-year.
  • VYOME HOLDINGS, INC. depreciation for fiscal 2024 was $22.00K, a 81.82% decline from fiscal 2023.
  • VYOME HOLDINGS, INC. depreciation for fiscal 2023 was $121.00K, a 63.33% decline from fiscal 2022.
  • VYOME HOLDINGS, INC. depreciation for fiscal 2022 was $330.00K, a 42.24% increase from fiscal 2021.
  • VYOME HOLDINGS, INC. depreciation for fiscal 2021 was $232.00K, a 1446.67% increase from fiscal 2020.
Period endDepreciation 3 monthDepreciation 3 month as first filedDepreciation 6 monthDepreciation 9 monthDepreciation 12 monthDepreciation 12 month as first filed
2025-06-30$4.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
$8.00K
10-Q · filed 2025-08-14
$13.00K
derived: sum of 3 quarters · filed 2025-08-14
$18.00K
derived: sum of 4 quarters · filed 2025-08-14
2025-03-31$4.00K
10-Q · filed 2025-05-20
$9.00K
derived: sum of 2 quarters · filed 2025-05-20
$14.00K
derived: sum of 3 quarters · filed 2025-05-20
$20.00K
derived: sum of 4 quarters · filed 2025-08-14
2024-12-31$5.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04
$10.00K
derived: sum of 2 quarters · filed 2025-04-04
$16.00K
derived: sum of 3 quarters · filed 2025-08-14
$22.00K
10-K · filed 2025-04-04
2024-09-30$5.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$11.00K
derived: sum of 2 quarters · filed 2025-08-14
$17.00K
10-Q · filed 2024-11-14
$24.00K
derived: sum of 4 quarters · filed 2025-08-14
2024-06-30$6.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
$12.00K
10-Q · filed 2025-08-14
$19.00K
derived: sum of 3 quarters · filed 2025-08-14
$58.00K
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$6.00K
10-Q · filed 2025-05-20
$13.00K
derived: sum of 2 quarters · filed 2025-05-20
$52.00K
derived: sum of 3 quarters · filed 2025-05-20
$90.00K
derived: sum of 4 quarters · filed 2025-05-20
2023-12-31$7.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04
$46.00K
derived: sum of 2 quarters · filed 2025-04-04
$84.00K
derived: sum of 3 quarters · filed 2025-04-04
$121.00K
10-K · filed 2025-04-04
2023-09-30$39.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$77.00K
derived: sum of 2 quarters · filed 2024-11-14
$114.00K
10-Q · filed 2024-11-14
$173.00K
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$38.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
$75.00K
10-Q · filed 2024-08-14
$134.00K
derived: sum of 3 quarters · filed 2024-08-14
$221.00K
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31$37.00K
10-Q · filed 2024-05-15
$96.00K
derived: sum of 2 quarters · filed 2024-05-15
$183.00K
derived: sum of 3 quarters · filed 2024-05-15
$273.00K
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$59.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
$146.00K
derived: sum of 2 quarters · filed 2024-04-01
$236.00K
derived: sum of 3 quarters · filed 2024-04-01
$330.00K
10-K · filed 2024-04-01
2022-09-30$87.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$177.00K
derived: sum of 2 quarters · filed 2023-11-09
$271.00K
10-Q · filed 2023-11-09
$371.00K
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$90.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07
$184.00K
10-Q · filed 2023-08-07
$284.00K
derived: sum of 3 quarters · filed 2023-08-07
$376.00K
derived: sum of 4 quarters · filed 2023-08-07
2022-03-31$94.00K
10-Q · filed 2023-05-15
$194.00K
derived: sum of 2 quarters · filed 2023-05-15
$286.00K
derived: sum of 3 quarters · filed 2023-05-15
$319.00K
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$100.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17
$192.00K
derived: sum of 2 quarters · filed 2023-04-17
$225.00K
derived: sum of 3 quarters · filed 2023-04-17
$232.00K
10-K · filed 2023-04-17
2021-09-30$92.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$125.00K
derived: sum of 2 quarters · filed 2022-11-14
$132.00K
10-Q · filed 2022-11-14
$139.00K
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$33.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19
$40.00K
10-Q · filed 2022-08-19
$47.00K
derived: sum of 3 quarters · filed 2022-08-19
$50.00K
derived: sum of 4 quarters · filed 2022-08-19
2021-03-31$7.00K
10-Q · filed 2022-05-23
$100.00K
10-Q · filed 2021-05-12
$14.00K
derived: sum of 2 quarters · filed 2022-05-23
$17.00K
derived: sum of 3 quarters · filed 2022-05-23
-$78.00K
derived: sum of 4 quarters · filed 2022-05-23
2020-12-31$7.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08
$10.00K
derived: sum of 2 quarters · filed 2022-04-08
-$85.00K
derived: sum of 3 quarters · filed 2022-04-08
$15.00K
10-K · filed 2022-04-08
$300.00K
10-K · filed 2021-03-12
2020-09-30$3.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
-$92.00K
derived: sum of 2 quarters · filed 2021-11-12
$8.00K
10-Q · filed 2021-11-12
2020-06-30-$95.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
$5.00K
10-Q · filed 2021-08-16
2020-03-31$100.00K
10-Q · filed 2021-05-12
2019-12-31$400.00K
10-K · filed 2021-03-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36